Deep Proteomic Investigation of Metabolic Adaptation in Mycobacteria under Different Growth Conditions

Author:

Zmyslia Mariia1,Fröhlich Klemens2,Dao Trinh134,Schmidt Alexander2,Jessen-Trefzer Claudia14ORCID

Affiliation:

1. Faculty of Chemistry and Pharmacy, University of Freiburg, Albertstrasse 21, 79104 Freiburg, Germany

2. Proteomics Core Facility, Biozentrum Basel, University of Basel, Spitalstrasse 41, 4056 Basel, Switzerland

3. Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Albertstrasse 19A, 79104 Freiburg, Germany

4. The Center for Integrative Biological Signaling Studies, University of Freiburg, 79104 Freiburg, Germany

Abstract

Understanding the complex mechanisms of mycobacterial pathophysiology and adaptive responses presents challenges that can hinder drug development. However, employing physiologically relevant conditions, such as those found in human macrophages or simulating physiological growth conditions, holds promise for more effective drug screening. A valuable tool in this pursuit is proteomics, which allows for a comprehensive analysis of adaptive responses. In our study, we focused on Mycobacterium smegmatis, a model organism closely related to the pathogenic Mycobacterium tuberculosis, to investigate the impact of various carbon sources on mycobacterial growth. To facilitate this research, we developed a cost-effective, straightforward, and high-quality pipeline for proteome analysis and compared six different carbon source conditions. Additionally, we have created an online tool to present and analyze our data, making it easily accessible to the community. This user-friendly platform allows researchers and interested parties to explore and interpret the results effectively. Our findings shed light on mycobacterial adaptive physiology and present potential targets for drug development, contributing to the fight against tuberculosis.

Funder

Deutsche Forschungsgemeinschaft

University of Freiburg

Publisher

MDPI AG

Subject

Clinical Biochemistry,Molecular Biology,Biochemistry,Structural Biology

Reference57 articles.

1. World Health Organization (2022). Global Tuberculosis Report 2022.

2. The Rise of Non-Tuberculosis Mycobacterial Lung Disease;Ratnatunga;Front. Immunol.,2020

3. Anti-tuberculosis treatment strategies and drug development: Challenges and priorities;Dartois;Nat. Rev. Microbiol.,2022

4. Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection;Barber;Cold Spring Harb. Perspect. Med.,2015

5. Tuberculosis drug discovery in the post-post-genomic era;Lechartier;EMBO Mol. Med.,2014

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3